Hospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (52)

2024

  1. Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary

    Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 288-299

  2. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports

  3. Consensus on the Approach to Hydrosaline Overload in Acute Heart Failure. SEMI/SEC/S.E.N. Recommendations

    Revista Espanola de Cardiologia

  4. Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry

    Medicina Clinica, Vol. 162, Núm. 4, pp. 157-162

  5. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial

    Revista Clinica Espanola, Vol. 224, Núm. 2, pp. 67-76

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry

    Future cardiology, Vol. 19, Núm. 6, pp. 323-332

  3. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  4. Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post-hoc analysis of the CLOROTIC trial

    European Journal of Heart Failure, Vol. 25, Núm. 10, pp. 1784-1793

  5. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

    European heart journal, Vol. 44, Núm. 5, pp. 411-421

  6. Current heart failure disease management and treatment in accredited units from cardiology and internal medicine in Spain

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 405-413

  7. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  8. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  9. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  10. Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction

    Future cardiology, Vol. 19, Núm. 6, pp. 333-342

  11. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice

    Future cardiology, Vol. 19, Núm. 6, pp. 343-351

2022

  1. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  2. Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

    World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466

  3. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  4. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864